Search

Your search keyword '"Kontto, Jukka"' showing total 305 results

Search Constraints

Start Over You searched for: Author "Kontto, Jukka" Remove constraint Author: "Kontto, Jukka"
305 results on '"Kontto, Jukka"'

Search Results

5. Somatic and psychiatric comorbidity in people with diagnosed gambling disorder: A Finnish nation‐wide register study.

6. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

7. High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium

9. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

10. Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use

12. Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort Project

14. Risk prediction of atrial fibrillation and its complications in the community using hs troponin I

15. Risk prediction of atrial fibrillation and its complications in the community using hs troponin I

16. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

17. Risk prediction of atrial fibrillation and its complications in the community using hs troponin I

18. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

21. Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States

23. Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation

24. Rare and low-frequency coding variants alter human adult height

25. Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation

29. Effectiveness of a Gamification Strategy to Prevent Childhood Obesity in Schools: A Cluster Controlled Trial

30. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

31. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

33. Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.

34. Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci

35. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death

36. Does Estimated Pulse Wave Velocity Add Prognostic Information? : MORGAM Prospective Cohort Project

37. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality

38. Does Estimated Pulse Wave Velocity Add Prognostic Information?:MORGAM Prospective Cohort Project

39. High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure:Results From the BiomarCaRE Consortium

40. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality

41. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes

43. Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death

44. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

47. Application of non-HDL cholesterol for population-based cardiovascular risk stratification:results from the Multinational Cardiovascular Risk Consortium

48. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

49. Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use

50. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population:Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium

Catalog

Books, media, physical & digital resources